Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin in COVID-19: A possible role beyond diabetes
Swati Sharma, Avik Ray, Balakrishnan Sadasivam
Diabetes Research and Clinical Practice (2020) Vol. 164, pp. 108183-108183
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Why does COVID-19 disproportionately affect older people?
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 985
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella, Maria Cristina Campopiano, Michele Mantuano, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 9, pp. 782-792
Open Access | Times Cited: 870
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
Carolyn T. Bramante, Nicholas E. Ingraham, Thomas A. Murray, et al.
The Lancet Healthy Longevity (2020) Vol. 2, Iss. 1, pp. e34-e41
Open Access | Times Cited: 211
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 184
Metformin and COVID-19: From cellular mechanisms to reduced mortality
André Scheen
Diabetes & Metabolism (2020) Vol. 46, Iss. 6, pp. 423-426
Open Access | Times Cited: 170
COVID-19 y diabetes mellitus: una relación bidireccional
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (2020) Vol. 33, Iss. 3, pp. 151-157
Open Access | Times Cited: 156
COVID-19 and diabetes: The why, the what and the how
Sarah Cuschieri, Stephan Grech
Journal of Diabetes and its Complications (2020) Vol. 34, Iss. 9, pp. 107637-107637
Open Access | Times Cited: 148
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
André Scheen, Michel Marre, Charles Thivolet
Diabetes & Metabolism (2020) Vol. 46, Iss. 4, pp. 265-271
Open Access | Times Cited: 143
Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 142
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista Poderoso, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 121
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 109
Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections
Thierry Gauthier, Wanjun Chen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto, Andree Kurniawan
Obesity Medicine (2020) Vol. 19, pp. 100290-100290
Open Access | Times Cited: 118
Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
Carolyn T. Bramante, Nicholas E. Ingraham, Thomas A. Murray, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 111
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
Ioannis Kyrou, Emmanouíl Karteris, Tim Robbins, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 107
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, et al.
iScience (2020) Vol. 23, Iss. 10, pp. 101631-101631
Open Access | Times Cited: 104
COVID-19 and diabetes: A bidirectional relationship
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2021) Vol. 33, Iss. 3, pp. 151-157
Closed Access | Times Cited: 97
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
Luis M. Pérez-Belmonte, José D. Torres‐Peña, Maria D. López‐Carmona, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 96
COVID-19, cytokines, inflammation, and spices: How are they related?
Ajaikumar B. Kunnumakkara, Varsha Rana, Parama Dey, et al.
Life Sciences (2021) Vol. 284, pp. 119201-119201
Open Access | Times Cited: 96
mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19
M. Janaki Ramaiah
Gene Reports (2020) Vol. 20, pp. 100765-100765
Open Access | Times Cited: 94
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis
Antonia Anna Lukito, Raymond Pranata, Joshua Henrina, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 2177-2183
Open Access | Times Cited: 92
Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis
Zixin Cai, Yan Yang, Jingjing Zhang
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 89
Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis
Chia Siang Kow, Syed Shahzad Hasan
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 695-697
Closed Access | Times Cited: 83
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
Samson Mathews Samuel, Elizabeth Varghese, Dietrich Büsselberg
Trends in Microbiology (2021) Vol. 29, Iss. 10, pp. 894-907
Open Access | Times Cited: 82
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, et al.
Archives of Virology (2021) Vol. 166, Iss. 3, pp. 675-696
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top